- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01229540
Clinical Research on Retinal Neovascularization of Diabetic Retinopathy
October 26, 2010 updated by: Tianjin Medical University
Retinal neovascularization of diabetic retinopathy might be associated with genetic risk factors and environmental risk factors.
Study Overview
Status
Terminated
Intervention / Treatment
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Tianjin
-
Tianjin, Tianjin, China, 300020
- Tianjin Eye Hospital, Clinical college of Ophthalmology ,Tianjin Medical Univercity
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
45 years to 74 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- T2DM was diagnosed according to the World Health Organization Expert Consultation Report 1999 and consisted of one of the following: fasting blood glucose (FBG) ≥7.0 mmol/L (≥126 mg/dL), blood glucose ≥11.1 mmol/L (≥200 mg/dL) 2 hours after an oral glucose tolerance test (OGTT); or a random blood glucose ≥11.1 mmol/L (≥200 mg/dL).
- DR was clinically graded in accordance with the International Clinical Diabetic Retinopathy guidelines based on fundus fluorescence angiography.
- All participants with PDR underwent a comprehensive dilated fundus examination to detect DR by indirect ophthalmoscopy and were diagnosed by fundus fluorescence angiography.
Exclusion Criteria:
- Patients were excluded if they had acute complications of diabetes mellitus, type 1 diabetes mellitus, other types of diabetes, serious cardiovascular, hepatic, nephritic or other complications, other serious primary diseases or mental illness.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Lifestyle counseling
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Registration Dates
First Submitted
October 26, 2010
First Submitted That Met QC Criteria
October 26, 2010
First Posted (Estimate)
October 27, 2010
Study Record Updates
Last Update Posted (Estimate)
October 27, 2010
Last Update Submitted That Met QC Criteria
October 26, 2010
Last Verified
September 1, 2008
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 08ZCGYSF01700 (Other Identifier: Tianjin Science and Technology Commission)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on The Mechanism of Retinal Neovascularization of Diabetic
-
Jie LiRecruitingThe Condition of Fundus NeovascularizationChina
-
Brigham and Women's HospitalHarvard Medical School (HMS and HSDM)RecruitingColchicine Mechanism of ActionUnited States
-
California Pacific Medical Center Research InstituteCompleted
-
Universitaire Ziekenhuizen KU LeuvenNot yet recruitingTo Evaluate the Added Value of the Use of Artificial Intelligence in the Diagnosis of Referable Diabetic Retinopathy in a Teaching Hospital Setting
-
Shanghai Eye Disease Prevention and Treatment CenterUnknownGlaucoma | Uveitis | Diabetic Retinopathy | Conjunctivitis | Myopia | Retinal Detachment | Retinal Neovascularization, Unspecified
-
VISUfarma SpACROlifeCompletedDiabetic Macular Edema | Proliferative Diabetic Retinopathy | Macular Degeneration, Age Related | Myopic Choroidal Neovascularisation | Macular Edema of Right Retina (Diagnosis)Italy
-
Moorfields Eye Hospital NHS Foundation TrustNovartisCompletedDiabetic Retinopathy | Retinal NeovascularisationUnited Kingdom
-
National Eye Institute (NEI)CompletedMacular Degeneration | Diabetic Retinopathy | Retinal Disease | Pathologic NeovascularizationUnited States
-
Novartis PharmaceuticalsCompleted
-
Elman Retina GroupCompletedRetinal NeovascularizationUnited States
Clinical Trials on genetic analyzer
-
Beijing Tiantan HospitalWest China Hospital; The First Affiliated Hospital of Zhengzhou University; Capital... and other collaboratorsRecruiting
-
Sight DiagnosticsCompleted
-
American University of Beirut Medical CenterCompleted
-
University of Maryland, BaltimoreHemoSonics LLCCompletedHemorrhage | Coagulation DelayUnited States
-
University of Mississippi Medical CenterVicor Technologies, Inc.CompletedAutonomic DysfunctionUnited States
-
Southern Medical University, ChinaNanfang Hospital of Southern Medical University; Zhujiang HospitalUnknown
-
Wills EyeOlleyes, Inc.CompletedGlaucoma, Open-AngleUnited States
-
Southern Medical University, ChinaZhujiang HospitalUnknown
-
National Taiwan University HospitalUnknown
-
Niels Henrik HolländerCompleted